Dendritic cell rehab: new strategies to unleash therapeutic immunity in ovarian cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 8, p. 969, doi. 10.1007/s00262-017-1958-2
- By:
- Publication type:
- Article
Works matching IS 03407004 AND DT 2017 AND VI 66 AND IP 8
Results: 15
1
2
Mechanisms overseeing myeloid-derived suppressor cell production in neoplastic disease.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 8, p. 989, doi. 10.1007/s00262-017-1963-5
- By:
- Publication type:
- Article
3
Myeloid cells as a target for oligonucleotide therapeutics: turning obstacles into opportunities.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 8, p. 979, doi. 10.1007/s00262-017-1966-2
- By:
- Publication type:
- Article
4
Phenotype and function of tumor-associated neutrophils and their subsets in early-stage human lung cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 8, p. 997, doi. 10.1007/s00262-017-1976-0
- By:
- Publication type:
- Article
5
CCR5 in recruitment and activation of myeloid-derived suppressor cells in melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 8, p. 1015, doi. 10.1007/s00262-017-1988-9
- By:
- Publication type:
- Article
6
Bone marrow myeloid cells in regulation of multiple myeloma progression.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 8, p. 1007, doi. 10.1007/s00262-017-1992-0
- By:
- Publication type:
- Article
7
Tumor-associated myeloid cells as guiding forces of cancer cell stemness.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 8, p. 1025, doi. 10.1007/s00262-017-1997-8
- By:
- Publication type:
- Article
8
Tumor-associated fibrosis as a regulator of tumor immunity and response to immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 8, p. 1037, doi. 10.1007/s00262-017-2003-1
- By:
- Publication type:
- Article
9
IDO, PTEN-expressing Tregs and control of antigen-presentation in the murine tumor microenvironment.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 8, p. 1049, doi. 10.1007/s00262-017-2010-2
- By:
- Publication type:
- Article
10
Common extracellular matrix regulation of myeloid cell activity in the bone marrow and tumor microenvironments.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 8, p. 1059, doi. 10.1007/s00262-017-2014-y
- By:
- Publication type:
- Article
11
Endoplasmic reticulum stress regulates tumor growth and anti-tumor immunity: a promising opportunity for cancer immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 8, p. 1069, doi. 10.1007/s00262-017-2019-6
- By:
- Publication type:
- Article
12
LILRB receptor-mediated regulation of myeloid cell maturation and function.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 8, p. 1079, doi. 10.1007/s00262-017-2023-x
- By:
- Publication type:
- Article
13
Immune biomarkers for chronic inflammation related complications in non-cancerous and cancerous diseases.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 8, p. 1089, doi. 10.1007/s00262-017-2035-6
- By:
- Publication type:
- Article
14
Regulatory myeloid cells: an underexplored continent in B-cell lymphomas.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 8, p. 1103, doi. 10.1007/s00262-017-2036-5
- By:
- Publication type:
- Article
15
Schwann cells: a new player in the tumor microenvironment.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 8, p. 959, doi. 10.1007/s00262-016-1929-z
- By:
- Publication type:
- Article